Sealonix closes on $20M in funding for orthopedic sealant

Sealonix, a biomaterials company, has closed on $20 million in series A funding to develop their next generation of hemostatic sealants for surgical use. The

Related Keywords

,Sealonix ,Biomaterials ,Sealant ,Hemostatic ,Ealant Patch ,Bdominopelvic ,Rthopedic ,Excelestar Ventures ,Clinical Trials ,